Hepatitis C virus antigenic convergence

Scientific Reports

Volumn 2, Issue , 2012, Pages

  Campo, David S ^a   Dimitrova, Zoya ^a   Yokosawa, Jonny ^a,b   Hoang, Duc ^a,c   Perez, Nestor O ^a,d   Ramachandran, Sumathi ^a   Khudyakov, Yury ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

^c NATIONAL INSTITUTE OF HYGIENE AND EPIDEMIOLOGY   (Viet Nam)

^d Probiomed SA de CV   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84859739733     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep00267     Document Type: Article

References (58)

1. Choo, Q. et al. Isolation of a cDNA Clone Derived From a Bloodborne Non-A, Non-B Viral Hepatitis Genome. Science 244, 359-362 (1989). (Pubitemid 19117877)
2. Torresi, J., Johnson, D. & Wedemeyer, H. Progress in the development of preventive and therapeutic vaccines for hepatitis C virus. JHepatol 54, 1273-1285 (2011).
3. Alberti, A., Chemello, L. & Benvegnu, L. Natural History of Hepatitis C. J Hepatol 31, 17-24 (1999). (Pubitemid 30002686)
4. Bowen, D. & Walker, C. Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 436, 946-952 (2005). (Pubitemid 41191670)
5. Simmonds, P. Genetic diversity and evolution of hepatitis C virus-15 years on. J Gen Virol 85, 3173-3188 (2004). (Pubitemid 39445434)
6. Houghton, M. Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses. Immunol Rev. 239, 99-108 (2011).
7. McBurney, S. & Ross, T. Viral sequence diversity: challenges for AIDS vaccine designs. Expert Rev Vaccines 7, 1405-1417 (2008).
8. Rerks-Ngarm, S. et al. Vaccination with ALVAC and AIDSVAX to preventHIV-1 infection in Thailand. N Engl J Med 361, 2209-2220 (2009).
9. Yang, O. Candidate vaccine sequences to represent intra-and inter-clade HIV-1 variation. PLoS One 4, e7388. (2009).
10. Kang, K. et al. Synthetic antigens representing the antigenic variation of human hepatitis C virus. Viral Immunol 23, 497-508 (2010).
11. Yusim, K. et al. Genotype 1 and global hepatitis C T-cell vaccines designed to optimize coverage of genetic diversity. J Gen Virol 91, 1194-1206 (2010).
12. El-Attar, L., Partidos, C. & Howard, C. Apeptidemimotope of hepatitis C virus E2 protein is immunogenic in mice and block human anti-HCV sera. JMed Virol 82, 1655-1665 (2010).
13. Roccasecca, R. et al. Mimotopes of the hyper variable region 1 of the hepatitis C virus induce cross-reactive antibodies directed against discontinuous epitopes. Mol Immunol 38, 485-492, doi:S0161589001000840 [pii] (2001). (Pubitemid 34008478)
14. Hamano, T. et al. Determination of HIV type 1 CRF01-AE gag p17 and env-V3 consensus sequences for HIV/AIDS vaccine design. AIDS Res Hum Retroviruses 20, 337-340 (2004).
15. Arenas, J. et al. Hepatitis C virus quasi-species dynamics predict progression of fibrosis after liver transplantation. J Infect Dis 189, 2037-2046 (2004). (Pubitemid 38692284)
16. Sheridan, I., Pybus, O., Holmes, E. & Klenerman, P. High-resolution phylogenetic analysis of hepatitis C virus adaptation and its relationship to disease progression. J Virol 78, 3447-3454 (2004). (Pubitemid 38568286)
17. Van Doorn, L. et al. Sequence evolution of the hypervariable region in the putative envelope region E2/NS1 of hepatitis C virus is correlated with specific humoral immune responses. J Virol 69, 773-778 (1995).
18. Eckels, D., Zhou, H., Bian, T. & Wang, H. Identification of antigenic escape variants in an immunodominant epitope of hepatitis C virus. Int Immunol 11, 577-583 (1999). (Pubitemid 29179006)
19. Pavio, N. & Lai, M. The Hepatitis C Virus Persistence: How To Evade The Immune System? J Biosci 3, 287-304 (2003). (Pubitemid 36512804)
20. Isaguliants, M. Hepatitis C virus clearance: the enigma of failure despite an impeccable survival strategy. Curr Pharm Biotechnol 4, 169-183 (2003). (Pubitemid 36665401)
21. Lopez-Labrador, F. et al. Genetic variability of hepatitis C virus NS3 protein in human leukocyte antigen-A2 liver transplant recipients with recurrent hepatitis C. Liver Transpl 10, 217-227 (2004). (Pubitemid 38240120)
22. Puntoriero, G. et al. Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants. EMBO J 17, 3521-3533 (1998). (Pubitemid 28327371)
23. Law, M. et al. Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge. Nat Med 14, 25-27 (2008).
24. Farci, P. et al. Prevention Of Hepatitis C Virus Infection In Chimpanzees By Hyperimmune Serum Against The Hypervariable Region 1 Of The Envelope 2 Protein. Proc Natl Acad Sci USA 93, 15394-15399 (1996).
25. Choo, Q. et al. Vaccination of chimpanzees against infection by the hepatitis C virus. Proc Natl Acad Sci USA. 91, 1294-1298. (1994). (Pubitemid 24058997)
26. Scarselli, E. et al. Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (gp70) hypervariable region 1 in viremic hepatitis C virus-infected patients. J Virol 69, 4407-4412 (1995).
27. Mondelli, M. U. et al. Antibody responses to hepatitis Cvirus hypervariable region 1: evidence for cross-reactivity and immune-mediated sequence variation. Hepatology 30, 537-545 (1999). (Pubitemid 29357522)
28. Cerino, A. et al. Monoclonal antibodies with broad specificity for hepatitis C virus hypervariable region 1 variants can recognize viral particles. J Immunol 167, 3878-3886 (2001). (Pubitemid 32910832)
29. Lesniewski, R. R. et al. Hypervariable 59-terminus of hepatitis C virus E2/NS1 encodes antigenically distinct variants. J Med Virol 40, 150-156 (1993). (Pubitemid 23169744)
30. da Silva, L. C. et al. Long term follow-up and patterns of response of ALT in patients with chronic hepatitis NANB/C treated with recombinant interferonalpha. Rev Inst Med Trop Sao Paulo 37, 239-243 (1995).
31. Jackson, P., Petrik, J., Alexander, G. J., Pearson, G. & Allain, J. P. Reactivity of synthetic peptides representing selected sections of hepatitis C virus core and envelope proteins with a panel of hepatitis C virus-seropositive human plasma. J Med Virol 51, 67-79, doi:10. 1002/(SICI)1096-9071(199701)51:167::AIDJMV11. 3. 0. CO;2-1 [pii] (1997). (Pubitemid 27059807)
32. Hjalmarsson, S., Blomberg, J., Grillner, L., Pipkorn, R. & Allander, T. Sequence evolution and cross-reactive antibody responses to hypervariable region 1 in acute hepatitis C virus infection. J Med Virol 64, 117-124 (2001).
33. von Hahn, T. et al. Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo. Gastroenterology 132, 667-678 (2007).
34. McCune, B. & Grace, J. Analysis of ecological communities. (MjM SoftwareDesign, 2002).
35. Albert, R. & Barabasi, A. Statistical mechanics of complex networks. Reviews of Modern Physics 74, doi:arXivcond-mat/0106096v1 (2002).
36. Watts, D. & Strogatz, S. Collective dynamics of small-world networks. Nature 393, 440-442 (1998).
37. Kuiken, C., Yusim, K., Boykin, L. & Richardson, R. The Los Alamos hepatitis C sequence database. Bioinformatics 21, 379-384 (2005). (Pubitemid 40246609)
38. Ramachandran, S., Xia, G. L., Ganova-Raeva, L. M., Nainan, O. V. & Khudyakov, Y. End-point limiting-dilution real-time PCR assay for evaluation of hepatitis C virus quasispecies in serum: performance under optimal and suboptimal conditions. J Virol Methods 151, 217-224 (2008).
39. Scotta, C. et al. Influence of specific CD41 T cells and antibodies on evolution of hypervariable region 1 during acute HCV infection. Journal of Hepatology 48, 216-228 (2008).
40. Hattori, M. et al. Broadly reactive antibodies to hypervariable region 1 in hepatitis C virus-infected patient sera: relation to viral loads and response to interferon. Hepatology 27, 1703-1710 (1998). (Pubitemid 28264698)
41. Yoshioka, K. et al. Humoral immune response to the hypervariable region of hepatitis C virus differs between genotypes 1b and 2a. J Infect Dis 175, 505-510 (1997). (Pubitemid 27086152)
42. Halperin, R., Stafford, P. & Johnston, S. Exploring Antibody Recognition of Sequence Space through Random-Sequence Peptide Microarrays. Mol Cell Proteomics 10 (2011).
43. Legutki, J., Magee, D., Stafford, P. & Johnston, S. A general method for characterization of humoral immunity induced by a vaccine or infection. 28, 4529-4537 (2010).
44. Penin, F. et al. Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment. J Virol 75, 5703-5710 (2001). (Pubitemid 32488166)
45. McAllister, J. et al. Long-term evolution of the hypervariable region of hepatitis C virus in a common-source-infected cohort. J Virol 72, 4893-4905 (1998). (Pubitemid 28215667)
46. Smith, D. Evolution of the hypervariable region of hepatitis C virus. J Viral Hepat 6, 41-46 (1999). (Pubitemid 29349788)
47. Wagner, P. Exhaustion of morphologic character states among fossil taxa. Evolution 54, 365-386 (2000). (Pubitemid 30263912)
48. Batagelj, V. & Mrvar, A. in Graph Drawing Software Mathematics and Visualization (eds M. Juenger & P. Mutzel) 77-103 (Springer, 2003).
49. Alvarez-hamelin, I., Dall'Asta, L. & Vespignani, A. k-core decomposition: a tool for the visualization of large scale networks. Advances in Neural Information Processing Systems 18 (2006).
50. Ramachandran, S. et al. Temporal Variations in the Hepatitis C Virus Intra-Host Population During Chronic Infection. J virol, doi:10. 1128/JVI. 02204-10 (2011).
51. Herring, B., Tsui, R. & Peddada, L. Wide Range of Quasispecies Diversity During Primary Hepatitis C Virus Infection. J virol 79 4340-4346 (2005). (Pubitemid 40388371)
52. Farci, P. et al. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 288, 339-334 (2000).
53. Nainan, O. et al. Hepatitis C virus genotypes and viral concentrations in participants of a general population survey in the United States. Gastroenterology 131, 478-484. (2006). (Pubitemid 44142463)
54. Farci, P. et al. Evolution of hepatitis C viral quasispecies and hepatic injury in perinatally infected children followed prospectively. Proc Natl Acad Sci USA 103, 8475-8480 (2006). (Pubitemid 43838480)
55. Beyer, K., Goldstein, J., Ramakrishnan, R. & Shaft, U. in Proceedings of the 7th International Conference on Database Theory (eds C. Beeri & P. Buneman) 217-235 (Springer-Verlag, Jerusalem, Israel., 1999).
56. Schvaneveldt, R., Durso, F. & Dearholt, D. Network structures in proximity data. The Psychology of learning and motivation 24, 249-283 (1989).
57. Schneider, S., Roessli, D. & Excoffier, L. ARLEQUIN version 2000: Software for population genetic data analysis. (2000).
58. Cade, B. & Richards, J. User Manual For BLOSSOM Statistical Software. Midcontinent Ecological Science Center US Geological Survey Fort Collins, Colorado (2001).